Literature DB >> 17823956

Pediatric drugs--a review of commercially available oral formulations.

Robert G Strickley1, Quynh Iwata, Sylvia Wu, Terrence C Dahl.   

Abstract

Pediatric oral formulations can be quite scientifically challenging to develop and the prerequisites for both a measurable dosage form to administer based upon bodyweight, and also taste-masking are two of the challenges unique for pediatric oral formulations. The physicochemical and organoleptic properties of the active drug substance such as solubility, chemical stability, and taste along with the intended dose can determine which formulations are feasible to develop. Oral pediatric formulations are available in 17 different varieties and can be either a ready-to-use formulation such as a solution, syrup, suspension, tablet, scored tablet, chewable tablet, orally disintegrating tablet, or thin strip, or can also be a formulation that requires manipulation such as a powder for constitution to a suspension, tablet for constitution to a suspension, powder for constitution to a solution, drops for reconstitution to a suspension, concentrated solution for dilution, effervescent tablet, bulk oral granules, bulk oral powder, or solid in a capsule to mix with food or drink. Recently there has been an increase in pediatric formulation development inspired by increased regulatory incentives. The intent of this review is to educate the reader on the various types of formulations administered orally to pediatrics, the rationale in deciding which type of formulation to develop, the excipients used, development challenges, the in-use handling of oral pediatric formulations, and the regulatory incentives.

Mesh:

Substances:

Year:  2008        PMID: 17823956     DOI: 10.1002/jps.21101

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment.

Authors:  Sophie Peigné; François Bouzom; Karl Brendel; Charlotte Gesson; Sylvain Fouliard; Marylore Chenel
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-11-12       Impact factor: 2.745

Review 2.  Formulations for children: problems and solutions.

Authors:  Hannah K Batchelor; John F Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

3.  UHPLC assay and impurity methods for diphenhydramine and phenylephrine hydrochloride oral solution.

Authors:  Douglas Kirkpatrick; Margaret Fain; Jingyue Yang; Leonel Santos; Clydewyn Anthony
Journal:  Sep Sci Plus       Date:  2020-01

Review 4.  Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.

Authors:  William Wei Lim Chin; Angelika Joos
Journal:  Eur J Pediatr       Date:  2016-09-19       Impact factor: 3.183

5.  3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.

Authors:  Nicolaos Scoutaris; Steven A Ross; Dennis Douroumis
Journal:  Pharm Res       Date:  2018-01-16       Impact factor: 4.200

Review 6.  A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.

Authors:  Anne Zajicek; Michael J Fossler; Jeffrey S Barrett; Jeffrey H Worthington; Robert Ternik; Georgia Charkoftaki; Susan Lum; Jörg Breitkreutz; Mike Baltezor; Panos Macheras; Mansoor Khan; Shreeram Agharkar; David Douglas MacLaren
Journal:  AAPS J       Date:  2013-08-02       Impact factor: 4.009

Review 7.  Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.

Authors:  B Ryan Phelps; Natella Rakhmanina
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

8.  Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.

Authors:  Manjeet B Pimparade; Joseph T Morott; Jun-Bom Park; Vijay I Kulkarni; Soumyajit Majumdar; S N Murthy; Zhuoyang Lian; Elanor Pinto; Vivian Bi; Thomas Durig; Reena Murthy; H N Shivakumar; K Vanaja; P C Kumar; Michael A Repka
Journal:  Int J Pharm       Date:  2015-04-15       Impact factor: 5.875

9.  The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.

Authors:  Joseph T Morott; Manjeet Pimparade; Jun-Bom Park; Chelsea P Worley; Soumyajit Majumdar; Zhuoyang Lian; Elanor Pinto; Yunxia Bi; Thomas Durig; Michael A Repka
Journal:  J Pharm Sci       Date:  2014-11-19       Impact factor: 3.534

10.  Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.

Authors:  H Lou; M Liu; L Wang; S R Mishra; W Qu; J Johnson; E Brunson; H Almoazen
Journal:  AAPS PharmSciTech       Date:  2013-06-13       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.